All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

What are the current treatment options for double-hit lymphoma?

Nov 9, 2022
Share:
Learning objective: After reading this article, learners will be able to cite a new clinical development in lymphoma.

During the COLYM 2022 Annual Meeting, the Lymphoma Hub spoke with Kieron Dunleavy, The George Washington Cancer Center, Washington, DC, US. We asked, What are the current treatment options for double-hit lymphoma?

What are the current treatment options for double hit lymphoma?

Dunleavy reviews outcome data for the intensive regimens used to treat double-hit lymphoma and makes comparisons to those used for Burkitt lymphoma. Dunleavy compares the challenges that older patients undergoing intensive treatment therapies face compared with younger patients and discusses novel treatment options for high-grade B-cell lymphomas, such as anti-CD19 CAR T cells.

Understanding your specialty helps us to deliver the most relevant and engaging content.

Please spare a moment to share yours.

Please select or type your specialty

  Thank you